Immunoglobulin m paraproteinaemias

Immunoglobulin m paraproteinaemias

10.3390/cancers12061688

Saved in:

Bibliographic Details
Main Authors:	Girard, L.-P., Soekojo, C.Y., Ooi, M., Poon, L.M., Chng, W.-J., de Mel, S.
Other Authors:	MEDICINE
Format:	Review
Published:	MDPI AG 2021
Subjects:	Immunoglobulin M Lymphoma Multiple myeloma Paraproteinaemia Waldenstrom macroglobulinaemia
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/197734
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
by: Girard, Louis-Pierre, et al.
Published: (2022)

Multiple Myeloma-Associated Light Chain Amyloidosis and a Proposed Approach to Monoclonal Immunoglobulin-Associated Renal Disease
by: Zi Yun Chang, et al.
Published: (2020)

Immunoglobulin-M purification - challenges and perspectives
by: Gautam, S., et al.
Published: (2014)

Biomimetic Ligands for Immunoglobulin-M Purification
by: SATYEN GAUTAM
Published: (2011)

Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma
by: Jen, W.-Y., et al.
Published: (2021)

Accuracy of AccessBio Immunoglobulin M and Total Antibody Rapid Immunochromatographic Assays for the Diagnosis of Acute Scrub Typhus Infection
by: Blacksell,Stuart D., et al.
Published: (2010)

Natural history and prognostic factors at first relapse in multiple myeloma
by: Wang, C., et al.
Published: (2021)

Potential clinical application of genomics in multiple myeloma
by: Soekojo, C.Y, et al.
Published: (2020)

Frequency of BCL-2 rearrangement, t(14; 18), in Thai patients with follicular lymphoma
by: Atjaraporn Chotipuech
Published: (2006)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023)

Extramedullary plasmacytoma of the orbit as initial presentation of multiple myeloma
by: Razak, R.A., et al.
Published: (2016)

Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in t(4;14) multiple myeloma
by: Xie, Z., et al.
Published: (2014)

Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
by: Li, Boheng, et al.
Published: (2022)

Attenuation of STAT3 signaling cascade by daidzin can enhance the apoptotic potential of bortezomib against multiple myeloma
by: Yang, M.H., et al.
Published: (2021)

Transmembrane activator and caml interactor (Taci): Another potential target for immunotherapy of multiple myeloma?
by: Xu, S., et al.
Published: (2021)

First report on the isolation of immunoglobulin M of guppy, Poecilia reticulata, for the production of polyclonal antibodies
by: Lim, S.-H., et al.
Published: (2011)

A unique rhinologic manifestation of multiple myeloma
by: Seah, Jun Jie, et al.
Published: (2022)

High concentration of IgM-κ paraprotein causes over-estimation of serum total protein by certain biuret method
by: Loh, T.P., et al.
Published: (2014)

Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of multiple myeloma
by: Sikka, S., et al.
Published: (2014)

Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis
by: Chong, Lip Leong, et al.
Published: (2021)

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
by: Kannaiyan, R., et al.
Published: (2014)

Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling cascade
by: Jung Y.Y., et al.
Published: (2019)

Study on the effects of exercise in lupus-prone mice
by: Supawan Visetnoi
Published: (2023)

Immunoglobulin class switching induced by plasmodium falciparum in vitro
by: Pachuen Potup
Published: (2023)

WHO guidelines dealing with immunoglobulin use impede rabies prevention
by: Anderson, David C.
Published: (2010)

Targeting nf-κb signaling for multiple myeloma
by: Wong, A.H.-H., et al.
Published: (2021)

Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.
by: Spencer, Andrew, et al.
Published: (2023)

Degradation of human secretory immunoglobulin a by Blastocystis
by: Puthia, M.K., et al.
Published: (2011)

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
by: Teoh, Phaik Ju, et al.
Published: (2019)

A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)
by: Chen, Yunxin, et al.
Published: (2021)

Basal immunoglobulin signaling actively maintains developmental stage in immature B cells
by: Tze L.E., et al.
Published: (2020)

Management of treatment-emergent peripheral neuropathy in multiple myeloma
by: Richardson, P.G., et al.
Published: (2016)

Unraveling genomic instability in multiple myeloma - Mechanisms, biological and clinical implications
by: CHNG WEE JOO
Published: (2011)

GLOBALLY OPTIMIZING THERAPEUTIC COMBINATIONS USING QUANTITATIVE PARABOLIC OPTIMIZATION PLATFORM (QPOP)
by: MASTURAH BTE MOHD ABDUL RASHID
Published: (2018)

ELUCIDATING THE ROLE OF ADAR1 IN REGULATING IMMUNOTHERAPEUTIC RESPONSE IN MULTIPLE MYELOMA
by: KOH MUN YEE
Published: (2023)

Conventional capillary electrophoresis in comparison with short-capillary capillary electrophoresis and microfabricated glass chip capillary electrophoresis for the analysis of fluorescein isothiocyanate anti-human immunoglobulin C
by: Rodriguez, I., et al.
Published: (2014)

The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network
by: Tan, D., et al.
Published: (2016)

Centrosomes and myeloma; aneuploidy and proliferation
by: Chng, W.J., et al.
Published: (2016)

KINASE-INDEPENDENT AND DEPENDENT MECHANISMS OF MAMMALIAN TARGET OF RAPAMYCIN IN MODULATING CELLULAR HOMEOSTASIS
by: TAN WEI QUAN BRYCE
Published: (2023)